CAMPOSTRINI, Natascia
 Distribuzione geografica
Continente #
NA - Nord America 4.558
EU - Europa 3.810
AS - Asia 2.764
SA - Sud America 405
AF - Africa 60
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.606
Nazione #
US - Stati Uniti d'America 4.481
RU - Federazione Russa 1.444
SG - Singapore 1.070
GB - Regno Unito 892
CN - Cina 865
BR - Brasile 321
VN - Vietnam 253
SE - Svezia 252
HK - Hong Kong 237
FR - Francia 227
IT - Italia 220
DE - Germania 202
IE - Irlanda 184
FI - Finlandia 183
KR - Corea 79
UA - Ucraina 63
JP - Giappone 60
CA - Canada 48
IN - India 45
AR - Argentina 35
NL - Olanda 30
TR - Turchia 28
BD - Bangladesh 25
BE - Belgio 24
ES - Italia 21
IQ - Iraq 18
NG - Nigeria 17
PL - Polonia 17
MX - Messico 16
ZA - Sudafrica 14
ID - Indonesia 12
EC - Ecuador 10
IR - Iran 9
PK - Pakistan 9
VE - Venezuela 9
AT - Austria 8
CL - Cile 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CO - Colombia 7
MA - Marocco 7
EG - Egitto 6
IL - Israele 6
LT - Lituania 6
UY - Uruguay 6
CH - Svizzera 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
HR - Croazia 4
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
SI - Slovenia 4
TN - Tunisia 4
GR - Grecia 3
HN - Honduras 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GD - Grenada 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MU - Mauritius 1
MW - Malawi 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 11.602
Città #
Southend 733
Singapore 613
Chandler 513
Jacksonville 480
Moscow 478
San Jose 404
Ashburn 401
Woodbridge 340
Dallas 296
Ann Arbor 234
Hong Kong 232
Houston 198
Dublin 184
Beijing 161
Verona 125
New York 103
The Dalles 103
Ho Chi Minh City 92
Council Bluffs 91
Lawrence 77
Princeton 77
Los Angeles 72
Wilmington 69
Lancaster 63
Nanjing 61
Jinan 59
Tokyo 59
Hanoi 51
Munich 48
Boardman 39
Santa Clara 39
São Paulo 35
Shenyang 34
Buffalo 32
Helsinki 31
Columbus 28
Tianjin 26
Nanchang 25
Redondo Beach 24
Orem 23
Brussels 22
Hebei 22
Montreal 21
Sindelfingen 21
Changsha 20
Hangzhou 20
Jiaxing 20
Haikou 19
Zhengzhou 19
Brooklyn 18
Guangzhou 18
Milan 18
Chennai 16
Ningbo 16
Norwalk 16
London 15
Taizhou 15
Abuja 14
Turku 14
Atlanta 13
Taiyuan 13
Toronto 13
Warsaw 13
Amsterdam 12
Redmond 12
Rio de Janeiro 12
San Francisco 12
Bologna 11
Denver 11
Poplar 11
Seattle 11
Stockholm 11
Lanzhou 10
Manchester 10
Boston 9
Fairfield 9
Haiphong 9
San Mateo 9
Shanghai 9
Chicago 8
Fuzhou 8
Hải Dương 8
Johannesburg 8
Ankara 7
Brasília 7
Dearborn 7
Dhaka 7
Madrid 7
Ardabil 6
Baghdad 6
Barnet 6
Belo Horizonte 6
Can Tho 6
Falls Church 6
Frankfurt am Main 6
Montevideo 6
Nuremberg 6
Thái Nguyên 6
Washington 6
Biên Hòa 5
Totale 7.455
Nome #
MOLECULARLY IMPRINTED NANOPARTICLES FOR HEPCIDIN CAPTURE: A SYNTHETIC ALTERNATIVE TO NATURAL ANTIBODIES 222
A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. 220
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 218
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 211
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 209
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 207
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 206
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 205
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 205
The proteome: anno Domini 2002 193
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 191
A Gain-of-Function Mutation on BCKDK Gene and Its Possible Pathogenic Role in Branched-Chain Amino Acid Metabolism 191
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 190
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 190
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 189
Altered paraoxonase expression in patients with genetic haemochromatosis. 189
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 188
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 185
Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing. 180
High-protein goat's milk diet identified through newborn screening: clinical warning of a potentially dangerous dietetic practice 180
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 175
“Proteomics approaches for studying chemoresistance in cancer” 173
Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. 170
Anticancer activity of a novel histone deacetylase inhibitor against human colorectal cancer cells 170
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 169
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 167
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 167
"Quantitative Proteomics" 165
“Application of Partial Least Squares Discriminant Analysis and variable selection procedures: a 2D-PAGE Proteomic-Based Study” 163
“Pre-fractionation for Hidden Proteome” 161
TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. 160
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience 160
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 159
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 158
Serum Hepcidin in Inflammatory Bowel Diseases: biological and clinical significance. 158
Proteomic analysis of S-nitrosylated proteins in Arabidopsis thaliana undergoing hypersensitive response 156
Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity 155
Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy 155
Association ofHFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. 154
Acquired iron overload associated with antitransferrin monoclonal immunoglobulin: a case report. 152
Hepcidin levels and their determinants in different types of myelodysplastic syndromes. 148
Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin 148
Does TMPRSS6 RS855791 Polymorphism Contribute to Iron Deficiency in Treated Celiac Disease? 148
“Numerical approaches for quantitative analysis of 2D map: a review of commercial software and of “home-made” systems” 144
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 143
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. 142
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 140
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 135
Reduced serum hepcidin levels in patients with chronic hepatitis C 135
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 135
Proteomic analysis of S-nitrosylated proteins in Arabidopsis during the disease resistance response 132
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 130
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 127
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. 123
Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. 122
Quantitative proteomics: a review of different methodologies. 121
Study of proteomic changes associated with healthy and tumoral murine samples in neuroblastoma by principal component analysis and classification methods. 119
Proteomic analysis of an orthotopic neuroblastoma xenograft animal model. 118
Formation of truncated proteins and high-molecular-mass aggregates upon soft illumination of photosynthetic proteins. 113
Omics | quantitative proteomics 111
Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material 110
Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line. 108
Urinary hepcidin identifies a serum ferritin cut-off for iron supplementation in young athletes: a pilot study. 108
Iron deficiency in the elderly population, revisited in the hepcidin era. 106
Two-dimensional mapping as a tool for classification of green coffee bean species. 105
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. 104
Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease 104
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo 102
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 102
PON1 activity and coagulation biomarkers: no association with thrombin generation parameters but an inverse correlation with D-dimer plasma concentration 100
Vitamin B12 Administration by Subcutaneous Catheter Device in a Cobalamin A (cblA) Patient 100
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 99
Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. 98
Hepcidin levels in chronic hemodialysis patients: a critical evaluation. 97
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization 96
Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA) 93
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 91
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo. 86
Totale 11.659
Categoria #
all - tutte 38.055
article - articoli 28.206
book - libri 0
conference - conferenze 7.917
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.932
Totale 76.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022547 34 145 11 65 20 16 6 27 20 15 62 126
2022/20231.345 90 142 129 216 146 317 23 79 156 4 27 16
2023/2024603 24 48 39 51 76 126 14 35 4 11 120 55
2024/20251.497 67 103 63 274 62 68 60 46 233 84 125 312
2025/20264.732 344 283 350 866 1.207 286 454 235 295 240 47 125
Totale 11.659